'Inconclusive' Gilead Remdesivir Reports Erase Stock Gains: What Wall Street's Saying
'Inconclusive' Gilead Remdesivir Reports Erase Stock Gains: What Wall Street's Saying

Positives on oil prices and fiscal stimulus were overwhelmed by a huge vaccine-related negative.